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Abstract
Background In patients with myelomeningocele (MMC),
a high number of fractures occur in the paralyzed
extremities, affecting mobility and independence. The aims
of this retrospective cross-sectional study are to determine
the frequency of fractures in our patient cohort and to
identify trends and risk factors relevant for such fractures.
Materials and methods Between March 1988 and June
2005, 862 patients with MMC were treated at our hospital.
The medical records, surgery reports, and X-rays from
these patients were evaluated.
Results During the study period, 11% of the patients
(n = 92) suffered one or more fractures. Risk analysis
showed that patients with MMC and thoracic-level para-
lysis had a sixfold higher risk of fracture compared with
those with sacral-level paralysis. Femoral-neck z-scores
measured by dual-energy X-ray absorptiometry (DEXA)
differed signiﬁcantly according to the level of neurological
impairment, with lower z-scores in children with a higher
level of lesion. Furthermore, the rate of epiphyseal sepa-
ration increased noticeably after cast immobilization.
Mainly patients who could walk relatively well were
affected.
Conclusions Patients with thoracic-level paralysis repre-
sent a group with high fracture risk. According to these
results, fracture and epiphyseal injury in patients with
MMC should be treated by plaster immobilization. The
duration of immobilization should be kept to a minimum
(\4 weeks) because of increased risk of secondary frac-
tures. Alternatively, patients with refractures can be treated
by surgery, when nonoperative treatment has failed.
Keywords Myelomeningocele  Fractures  Risk factors 
Risk analysis  Lesion level  Bone mineral density
Introduction
Neural tube anomalies develop at a rate of 2–9 per 1,000
births in Central Europe and North America [4, 13, 20]. In
2005 the rate of myelomeningocele (MMC) was 18.0 per
100,000 births in the USA [7]. Thus, it represents the third
most common birth defect after cleft lip and palate and
anomalies of the extremities.
The main focus of orthopedic care in MMC is preven-
tion and treatment of skeletal malformations of the spine
and the extremities. Preservation of maximum walking
ability [28] is an example of a functional goal. A major
obstacle for developmental rehabilitation is the increased
incidence of fractures in the paralyzed lower extremities,
which restrict mobility and independence of the children
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[10, 12, 14, 18, 21, 22].
Children with MMC are at increased risk of pathological
fractures due to motor and sensory deﬁcits and disuse of
lower limbs compared with their able-bodied peers. It has
been demonstrated that children with MMC have a bone
mineral density one to two standard deviations below the
mean of the normal population [32].
Fractures complicate the management of children who
have MMC [1, 6, 10, 12, 13, 20, 23, 24, 27, 33, 45]. A
fracture most often causes painless swelling, hyperthermia,
and hyperemia in the affected limb [10, 23, 41, 42, 45].
Furthermore, fever and leukocytosis can develop and the
erythrocyte sedimentation rate can increase, which delays
diagnosis [1, 6, 16, 23, 24, 27, 33, 41, 42, 45].
Radiographs and often follow-up X-rays are the key to
correct diagnosis, as fracture patterns are unique and dif-
ferent from those seen in children who are neurologically
intact [16, 27, 41, 45].
In some studies the prevalence of fractures has been
reported to be between 9% [31] and 20% [5, 9, 10, 21, 23,
30, 33, 34, 45]. Epiphyseal fractures occur frequently in
patients with MMC at rates of 4–9% [8, 9, 28] and can
affect further bone growth. In contrast to other kinds of
fractures, epiphyseal injuries mainly seem to affect those
MMC children who can walk relatively well [24, 27].
Some authors have already suggested that the level of
paralysis may be an inﬂuencing factor in fracture devel-
opment [9, 27, 30], but they did not analyze their data
statistically due to the small number of cases. Studies have
shown conﬂicting results in the incidence of fractures in
MMC children who ambulate compared with those who
use wheelchairs [26, 32, 37].
As fractures pose a considerable risk to physical
development and independence, the aims of this retro-
spective cross-sectional study are to determine the fre-
quency and location of fractures in our patient cohort, to
identify factors that promote fractures, to correlate bone
mineral density to fracture incidence, and to recommend
suitable treatment options.
Materials and methods
For this retrospective cross-sectional study, the records of
862 patients with MMC who had been treated as inpatients
and outpatients at our hospital from 1988 to 2005 were
reviewed in our database.
All the patients gave informed consent prior to being
included into the study. The study was authorized by the
local ethical committee and was performed in accordance
with the ethical standards of the 1964 Declaration of Hel-
sinki as revised in 2000.
MMC patients were usually incorporated into our inpa-
tientandoutpatientcareafterbirth,withcarecontinuingpast
adolescence. We saw these patients at least three times a
year. When problems arose that exceeded the capabilities of
an outpatient service, our patients were hospitalized. The
average time of care for these patients was 15 years [range
4–26 years, standard deviation (SD) 5 years].
Out of 862 patients, 471 were female (54.6%) and 391
were male (45.4%). During this period, 92 patients (10.7%)
suffered 170 fractures (Fig. 1). Of these 92 patients, 52
were female (56.5%) and 40 were male (43.5%). The
female patients suffered 99 fractures (58.2%) and the male
patients suffered 71 fractures (41.8%).
Average age at time of fracture occurrence was
10.2 years (range 0–33 years, SD 7.0 years). Between 8
and 14 years the rate of ﬁrst fracture occurrence remained
high, after which it quickly declined.
Demographic data and the level of paralysis, divided into
thoracic, high lumbar (L1-3), low lumbar(L4/5), and sacral,
were reviewed. In cases of documented fractures, we also
evaluatedtheX-raysand,ifavailable,thesurgeryreports.For
these patients we recorded their walking ability at the time of
fracture, symptoms, fracture site, cause, and treatment.
Ambulation was classiﬁed according to Hoffer et al.
[19]. In contrast to Hoffer et al. [19], who excluded chil-
dren under 5 years from their study, we classiﬁed all
patients using this system.
Surgery or immobilization in a cast was assumed to have
triggered the fracture when this had taken place in a period
of up to 12 weeks before the fracture occurred.
In 29 MMC patients with various levels of neurological
impairment (thoracic, n = 16; upper lumbar, n = 8; and
lower lumbar, n = 5) and ambulatory status according to
Hoffer et al. [19] (community ambulators, n = 3; house-
hold ambulators, n = 7; nonambulators, n = 19) bone
mineral density (BMD) of the femoral neck using dual-
energy X-ray absorptiometry (DEXA) was available after
fracture occurrence [3].
Statistical methods
For data entry, we used Microsoft
TM Excel. For statistical
analysis we used SAS
TM version 9.1 for Windows.
To analyze the fracture risk with respect to level of
paralysis we applied the Cochrane-Armitage trend test and
logistic regression. To calculate odds ratios of the fracture
risk for ordinal response (level of paralysis) we applied
logistic regression. Chi-square test was used to analyze
categorical variables. Analysis of variance was used to
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z-scores between level of neurological impairment and
ambulatory status. Boxplots were used to visualize the
ﬁndings. Level of signiﬁcance a was set to 0.05.
Results
Between March 1988 and June 2005, 862 MMC patients
were treated at our hospital. During this period, 92 patients
(10.7%) suffered 170 fractures (Fig. 1). The etiology of the
fractures is summarized in Table 1. Out of 92 patients, 56
suffered one fracture, 20 suffered two fractures, and the
other 16 patients suffered three or more fractures, 10
fractures being the maximum in the study period. Patients
only complained of pain in 8% of fractures. The most
commonly reported symptom was swelling in the area of
the fracture (83%), followed by local hyperthermia (33%),
fever (17%), and redness (14%).
In 37.9% of cases the femoral shaft was fractured.
Second most often (34.1%), the area around the knee
joint was affected (supracondylar femur, tibial head, and
infracondylar tibia) (Table 2).
Among these 862 patients, the level of paralysis was
nearly equally distributed among thoracic (31.3%), high
lumbar (28.8%), and low lumbar (33.2%), whereas nearly
60% of the patients treated for a fracture were paralyzed at
the thoracic level (Table 3).
Level of paralysis and fracture risk
The level of paralysis of the 92 MMC patients who were
treated for fractures at our hospital was considerably
higher as compared with the 770 patients of our cohort
who never sustained any fractures. Thus, thoracic paral-
ysis was found in the fracture group almost twice as often
as in the total cohort (59.8% vs. 31.3%). The frequency of
low lumbar and sacral paralysis was nearly 40%, whereas
only 14% of the patients who suffered a fracture
demonstrated a low lumbar or sacral level of paralysis.
Univariate analysis of risk showed a signiﬁcant trend
(Cochrane-Armitage trend test) towards more fractures
with respect to increasing level of paralysis (from sacral
3.5% to thoracic 17.8%). Logistic regression analysis gave
similar results. The risk of breaking a bone was sixfold
higher for thoracic-level paralysis than for sacral-level
paralysis (Table 4).
Fig. 1 This 3.5-year-old girl (neurosegmental level of lesion below
L3) sustained a fracture of the left lower leg with no history of injury.
Bilateral clubfoot surgery with subsequent 10-week plaster cast
immobilization had been performed 11 weeks prior to the fracture.
The fracture was treated by cast immobilization. Approximately
4 months later, the patient sustained a fracture of the proximal
epiphyseal plate of the tibia, again without any history of trauma. The
fracture was immobilized in a long leg cast for 7 weeks
Table 1 Fracture etiology
Etiology of fractures Number of fractures,
n (% of total fractures)
Fall 59 (35)
Transfer 28 (16)
Cast immobilization 62 (37)
Unknown 21 (12)
Total 170 (100)
Table 2 Fracture distribution
Location of fractures Number of fractures,
n (% of total fractures)
Femur, neck 5 (3)
Femur, intertrochanteric 2 (1)
Femur, subtrochanteric 13 (8)
Femur, shaft 64 (38)
Femur, supracondylar 39 (23)
Femur, distal epiphyseal plate 4 (2)
Tibia, condylar 5 (3)
Tibia, proximal epiphyseal plate 1 (1)
Tibia, infracondylar 9 (5)
Tibia, shaft 11 (6)
Tibia, supramalleolar 10 (6)
Tibia, distal epiphyseal plate 5 (3)
Metatarsal 5 1 (1)
Radius, distal 1 (1)
Total 170 (100)
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mainly femur fractures (81%) occurred, while at a lumbar
level of paralysis, the tibia was more often affected.
Bone mineral density, level of lesion, and ambulatory
status
The mean femoral-neck z-score was -3.81 (range -3.89 to
-3.69) for the patients (n = 16) with a thoracic level of
lesion, -2.93 (range -2.99 to -2.67) for the patients
(n = 8) with upper lumbar level of neurological impair-
ment, and -2.07 (range -2.23 to -1.9) for the patients
(n = 5) with lower lumbar level of lesion.
Femoral-neck z-scores differed signiﬁcantly (P\
0.0001) according to the level of neurological impairment
(Fig. 2), with lower z-scores in children with a higher level
of lesion.
The mean femoral-neck z-score was -3.67 (range
-3.89 to -2.89) for the nonambulators (wheelchair
dependent), -2.69 (range -2.95 to -2.10) for the house-
hold ambulators, and -2.04 (range -2.23 to -1.90) for the
community ambulators.
Femoral-neck z-scores differed signiﬁcantly (P\
0.0001)betweennonambulators,householdambulators,and
community ambulators (Fig. 3).
Epiphyseal fractures
A total of nine patients suffered ten epiphyseal fractures
(separation). Six patients were female. Average age at time
of epiphyseal injury was 8.9 years (range 3.5–15.3 years).
At the time of the epiphyseal separation, four patients were
between 3 and 4 years of age, and another four patients
were between 11 and 13 years of age.
Among the other 83 patients who did not suffer epiph-
yseal injury, ambulation was only classiﬁed as good in 16%
(class 1 according to Hoffer et al. [19]). In contrast, only
one single patient who suffered epiphyseal injury could not
walk (class 4 according to Hoffer et al. [19]) (Table 5).
Thus, ambulation in patients who suffered epiphyseal
injury was signiﬁcantly better than in the total cohort
(P\0.04).
After immobilization in a cast, epiphyseal separations
occurred seven times, six of these postoperatively. In one
Table 3 Distribution of level of lesion in our study population and in
patients who sustained a fracture
Level of lesion All patients
(%)
Patients with
fractures (%)
Thoracic 270 (31.3) 55 (59.8)
Upper lumbar (L1-L3) 248 (28.8) 24 (26.1)
Lower lumbar (L4 ? L5) 286 (33.2) 12 (13.0)
Sacral 58 (6.7) 1 (1.1)
Total 862 (100) 92 (100)
Table 4 Logistic regression analysis: risk to sustain a fracture at
different neurological level of lesion
Level of lesion Number of fractures
(%), n = 170
Odds ratio
[95% CI]
Thoracic 105 (61.8) 6.1 [1.4; 26.0]
L1-L3 45 (26.5) 2.9 [0.7; 12.6]
L2-L5 19 (11.2) 2.0 [0.5; 8.8]
Sacral 1 (0.6)
CI, conﬁdence interval
Fig. 2 BMD (z-score) in myelomeningocele patients with different
level of neurological impairment. 1 thoracic level. 2 upper lumbar
level. 3 lower lumbar level
Fig. 3 BMD (z-score) in myelomeningocele patients with different
ambulatory abilities. 1 nonambulators. 2 household ambulators.
3 community ambulators
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123case, epiphyseal injury occurred with low-impact trauma,
and in one case no cause of injury was recorded in the
patient’s medical history. The total of nine epiphyseal
injuries made up 5.3% of all fractures. Of the other 161
fractures, 55 (34.2%) could be associated with cast
immobilization, and therefore damage to the epiphyseal
plate was found more often after cast immobilization.
The average duration of cast immobilization associated
with subsequent epiphyseal injury was 6.1 weeks (range
4–10 weeks, SD 2 weeks). The mean time before epiphy-
seal injury occurred after the cast was removed was
2 weeks (range 0–5 weeks, SD 2 weeks).
Patients with epiphyseal injuries were immobilized for
6.6 weeks on average (range 6–9 weeks) to achieve satis-
factory healing.
Factors relevant in fractures
With respect to ambulation in these patients according to
the classiﬁcation of Hoffer et al. [19], a considerable
increase in fractures was found in class 3 (nonfunctional
ambulators) and class 4 patients (nonambulators).
Of all fractures, 74.1% were found in class 3 and class 4
patients (Table 6). In contrast, fractures were far rarer in
class 1 (community ambulators) and class 2 (household
ambulators) patients.
Patients who could not walk well or not walk at all
(class 3 and 4) suffered mostly femoral fractures. The
proportion of fractures in the tibial area was higher in those
patients who could walk moderately well to well (class 1
and 2).
Patients who suffered fractures of the femoral shaft were
treated with a femoral brace (73%) signiﬁcantly more often
(P\0.001) before fracture occurrence.
For patients who suffered a fracture, the gender dis-
tribution was similar: 57% (n = 52) were female and
43% (n = 40) were male. For the probability of suffering
a fracture, however, there was no gender-speciﬁc
preference.
Immobilization as cause of fracture
Some 37% of fractures (n = 62) were associated with
previous cast immobilization. In our cohort, 26.5% of
fractures (n = 45) had received a cast and were immobi-
lized for over 4 weeks. Most of the fractures occurred after
a cast immobilization period of more than 4 weeks on
average.
Overall, 538 of 862 patients were not immobilized. Out
of 538 patients, 58 (11%) were not immobilized prior to
fracture occurrence. Out of 862 patients, 253 were immo-
bilized for less than 4 weeks, 10 of whom (4%) developed
a fracture after immobilization. Out of 862 patients, 71
were immobilized for more than 4 weeks, 24 of whom
(34%) developed a fracture after immobilization. Fracture
occurrence was signiﬁcantly higher (P\0.0001) in the
patient group immobilized for more than 4 weeks.
Fracture treatment
A total of 32 patients who suffered a ﬁrst fracture (34.8%)
were treated operatively with locking plates, and addi-
tionally 15 patients (23.7%) with a refracture received
surgical treatment. None of the 45 patients with operatively
treated fractures suffered refracture or multiple fractures. In
the group of patients (n = 60) with non-operative-treated
(cast immobilization) fractures the rate of refractures was
very high: 98.3% (n = 59). The 59 patients with refrac-
tures were treated in 14 cases operatively and in 45 cases
nonoperatively. Fifteen multiple fractures occurred only in
the non-operative-treated patient group. Refracture and
multiple fracture occurrence was signiﬁcantly higher
(P\0.0001) in the non-operative-treatment group.
Discussion
In recent years, progress has been made in the areas of
surgical and conservative treatment and in our under-
standing of MMC. A considerable amount of information
about the particular aspects of fractures in MMC stems
from studies published between the 1960s and 1980s that
Table 5 Comparison of the ambulatory status of patients who had
epiphyseal fractures and patients who had other type of fractures
Ambulatory status Patients with
epiphyseal plate
fractures, n (%)
Patients
with other
fractures, n (%)
Community ambulators 5 (56) 13 (16)
Household ambulators 1 (11) 9 (11)
Nonfunctional
ambulators
2 (22) 29 (35)
Nonambulators 1 (11) 32 (38)
Total 9 (100) 83 (100)
Table 6 Fracture distribution with respect to ambulation according
to the classiﬁcation of Hoffer et al. [19]
Ambulation Number of
patients (%)
Number of
fractures (%)
Class 1 (community ambulators) 18 (19.6) 30 (17.7)
Class 2 (household ambulators) 10 (10.9) 14 (8.2)
Class 3 (nonfunctional ambulators) 31 (33.7) 66 (38.8)
Class 4 (nonambulators) 33 (35.9) 60 (35.3)
Total 92 (100) 170 (100)
J Orthopaed Traumatol (2010) 11:175–182 179
123often included only a small number of patients. Utilizing
our extensive patient cohort we can re-evaluate older
ﬁndings and assumptions.
During the study period, 92 patients with MMC suffered
one or more fractures, corresponding to a rate of 11%.
Older studies have indicated a prevalence of between 9%
and 20% [5, 9, 10, 21, 23, 30, 33, 34, 45].
The fracture risk for patients with MMC is sixfold
higher in cases of thoracic-level paralysis than in sacral-
level paralysis. The inﬂuence of level of paralysis on
fracture risk has already been discussed by Lock and
Aronson [27], Parsch und Rossak [30], and Dosa et al. [9]
with respect to smaller patient groups (186, 120, and 221
patients). However, the relative risk was not statistically
analyzed because of the small numbers and the lack of data
for comparison.
In the study conducted by Lock and Aronson [27] high
lumbar level of paralysis was found most often, in 15/37
MMC patients who suffered fractures (41%). In their study,
thoracic level of paralysis was reported for 13 of 37 chil-
dren (35%), low lumbar for 8 (22%), and sacral for 1 child
(3%). In spite of the less obvious distribution pattern, they
also concluded that fracture prevalence could be directly
related to level of paralysis [27].
Parsch and Rossak [30] reported broken legs in 11 of
120 treated children with MMC. Here, too, thoracic level
of paralysis was predominant. Seven of 11 MMC children
who suffered fractures (64%) had thoracic, three (28%)
lumbar, and one child (9%) sacral level of paralysis.
Dosa et al. [9] also considered higher situated level of
paralysis as a possible risk factor [9]. Interestingly, how-
ever, the mid-lumbar area (L3) was the dominant level of
paralysis in their patient cohort (46.5% of patients with
fractures, 20/43). Another 34.9% of the patients presented
with low lumbar level of paralysis (L4/5). Only 18.6%
demonstrated thoracic/high lumbar level of paralysis
(D/L2-3), in contrast to our patients in whom 62% of all
fractures (105/170) occurred in those who were paralyzed
at the thoracic level.
The differences between patient groups may explain
this. In the study by Dosa et al. [9], 49% of all patients
(51% of the patients who suffered fractures) were between
19 and 58 years old, and 47% of the patients were ambu-
latory, i.e., they were considerably older and could walk
better than our study patients could.
Our study showed that, with increasingly higher level of
paralysis and associated loss of walking ability, the fracture
risk increased too. One of the main reasons for a higher
prevalence of thoracic-level and high lumbar-level paral-
ysis might be the pronounced osteoporosis that develops in
MMC patients due to the lack of vertical load [1, 9, 14, 21,
24, 25, 29, 35, 36]. Our data showed that there is a sig-
niﬁcant relationship with low BMD in children with MMC
who are wheelchair dependent (nonambulators), and those
with higher neurological levels. Unfortunately, the DEXA
measurement was not performed routinely. Bone mineral
density was available in only 29 patients. Because of small
sample size, the data should be interpreted critically. It is
worthwhile mentioning that the statistical power was very
high.
These results are conﬁrmed by the work of Apkon
et al. [2].
There have been conﬂicting results in studies looking at
the association of ambulatory status, neurological level of
lesion, and bone mineral density [37, 43]. We cannot draw
any conclusions concerning the relationship between frac-
ture and reduced BMD because of the study design and
missing data.
According to the literature, preventive measures should
be carried out in MMC patients so that fractures do not
occur: consistent physiotherapy, vertical load [1, 22, 29],
concentrating necessary corrective surgery into a few ses-
sions at short intervals [5, 11], and short duration of cast
immobilization [30, 42] with early loading. There is no
data available concerning appropriate amount of weight
bearing and ambulation necessary to maintain or increase
bone mineral density in this population.
If there is evidence of vitamin D deﬁciency and/or poor
dietary calcium intake, it would be appropriate to replace
such deﬁcits, but routine calcium and vitamin D supple-
ments are not recommended [39]. In children with reduced
mobility, there is evidence that increased duration of
standing will improve bone density in the spine and femur
[39].
In the management of children who have sustained
osteoporotic fractures, the treatment for which there is
currently most evidence of beneﬁt is bisphosphonates
[39, 40].
Although there are many different bisphosphonates now
available, varying in potency and method of administra-
tion, most of the studies undertaken in children have uti-
lised the i.v. preparation pamidronate [15, 17, 38, 39, 44],
in doses ranging from 2 to 15 mg per kg per year. For the
treatment of our children with MMC with sustained frac-
ture, in a few cases we have followed the recommendations
of the published literature. The recommendation that bis-
phosphonate therapy is suitable to treat osteopenia in MMC
is not based on our own study results.
Epiphyseal separations accounted for 6% (n = 10) of
the fractures in our patients. In the literature, ﬁgures
ranging from 4% to 9% have been reported [8, 9, 27]. The
relatively good walking ability of patients who suffered
epiphyseal fractures is in line with observations made by
Kumar et al. [24], who reported that epiphyseal fractures
occur most often in ambulatory patients with low lumbar
paralysis.
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fractures that occur in patients with MMC, in terms of both
etiology and treatment. Mainly patients who can walk well
or moderately well (class 1 and 2 according to Hoffer et al.
[19]) are affected. If treated conservatively, particularly
early and long duration of immobilization are needed to
prevent damage to the epiphyseal cartilage, which in turn
carries the risk of secondary fractures [23, 30, 34]. Espe-
cially for the group of patients who can walk quite well, this
represents a high risk that walking ability could worsen.
It was striking in our patients that seven of nine
instances (78%) of epiphyseal injury were preceded by cast
immobilization; for the rest of the fractures this only
occurred in 62 fractures (37%) in 34 patients. In the per-
tinent literature this connection was not reported, and
although nine epiphyseal injuries are not sufﬁcient to
establish a statistically signiﬁcant relationship, these results
should prompt further studies. A popular explanation for
epiphyseal injury without low-impact trauma in MMC
patients has been that microtraumas occurred repeatedly
without a sensory protective mechanism being in place
[12, 18, 24, 42].
Epiphyseal separation requires immobilization for
between 6 and 9 weeks to achieve satisfactory healing,
which is considerably longer than for fractures in which the
epiphysis is not involved [24, 31, 35]. Pfeil et al. [31]
recommend surgery as a course of action in these cases,
because of the inherent danger of epiphyseal nonunion,
usually by transcutaneous ﬁxation with Kirschner wires in
combination with immobilization. Roberts et al. [35] rec-
ommend no loading and stopping physiotherapy for at least
4 weeks. Indeed, Kumar et al. [24] recommend cast
immobilization for at least 8 weeks and no loading until
X-rays show signs of consolidation.
However, since the risk of secondary fractures increases
considerably with immobilization for a longer time period
[1, 10, 21–23, 27, 30, 31, 33, 36], in addition to surgery,
vertical load should be applied early on, depending on
X-ray signs of consolidation.
In our patients, cast immobilization over a period of
4 weeks was found to be the cause of fracture in 37%
(n = 62)ofcases,whichislowerthanthevaluesof43%and
52% reported in the literature [30, 33]. These comparatively
low rates in our patients might indicate a positive trend as a
result of knowledge gained in the past few decades.
Wearing braces represents another possible risk factor in
patients who have suffered femoral shaft fractures. Whe-
ther this ﬁnding reﬂects more the level of paralysis and
degree of walking ability or whether forces acting at the
proximal end of the orthotic device promote the fractures
cannot be fully explained here.
The possible limitations of our study are: (1) because of
the study design (retrospective cross-sectional study) we
had no inﬂuence on data collection (missing data), and (2)
not routinely performed DEXA measurements (selection
bias).
It is worthwhile mentioning that this is the ﬁrst study
with such a high number of patients.
Patients with thoracic-level paralysis represent a group
of MMC patients with high fracture risk. Postoperative
long-term immobilization ([4 weeks) with a cast should be
avoided if possible to reduce the risk of secondary frac-
tures. Prevention of fractures in the postoperative period
includes starting the child on weight bearing as soon as
possible, but carefully, and making every effort to mini-
mize the plaster immobilization time. Once a fracture has
occurred, refracture and multiple fracture rates were found
only in the nonoperative group treated with plaster
immobilization for over 4 weeks.
Based on these results we recommend treating fractures
with plaster for not more than 4 weeks. Alternatively,
patients with refractures can be treated by surgery, when
nonoperative treatment has failed.
Failure to follow this principle may lead to increased
osteoporosis, muscle atrophy, and refractures. Considering
the peculiar circumstances in fractures in patients with
MMC in terms of both diagnosis and treatment, we rec-
ommend that these children be treated in outpatient clinics
of specialized centers where available and receive routine
checkups frequently.
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